Biologic and Systemic Agents in Dermatology

<div>Chapter 1 – Tumor Necrosis Factor Inhibition in the Treatment of Psoriasis and Psoriatic Arthritis</div><div><br/></div><div><br/></div><div>Chapter 2 – Therapies Targeting Interleukin-23 in Psoriatic Disease</div><div><br/></div><div><br/></div><div>Chapter 3 – Interleukin 17 – Pathogenesis in Psoriatic Disease and Treatment through Selective        Blockade</div><div><br/></div><div><br/></div><div>Chapter 4 – Conventional Systemic Agents for Psoriatic Disease </div><div><br/></div><div><br/></div><div>Chapter 5 – The Role of JAK Kinase Inhibitors in Psoriatic Disease and Other Dermatologic Conditions</div><div><br/></div><div><br/></div><div>Chapter 6 – PDE4 Inhibition in the Treatment of Psoriasis Disease and Other Skin Conditions</div><div><br/></div><div><br/></div><div>Chapter 7 – Miscellaneous Use of Biologic and Systemic Agents in Other Dermatologic Conditions</div><div><br/></div><div><br/></div><div>Chapter 8 – Targeting Interleukin 4 and Interleukin 13 in the Treatment of Atopic Dermatitis</div><div><br/></div><div><br/></div><div>Chapter 9 – Oral Agents for Atopic Dermatitis</div><div><br/></div><div><br/></div><div>Chapter 10 – Role of Intravenous Immunoglobulin in Dermatologic Disorders</div><div><br/></div><div><br/></div><div>Chapter 11 – Selective Targeting of CD20 on B Cells in Pemphigus Vulgaris and Other Dermatologic Diseases</div><div><br/></div><div><br/></div><div>Chapter 12 – Oral Systemic Agents for Various Immunobullous Disorders</div><div><br/></div><div><br/></div><div>Chapter 13 – Anti-IgE Therapy in Dermatology</div><div><br/></div><div><br/></div><div>Chapter 14  - Oral Retinoids in Dermatology</div><div><br/></div><div><br/></div><div>Chapter 15 – Updates in Immunotherapies for Melanoma</div><div><br/></div><div><br/></div><div>Chapter 16 – Sonic Hedgehog Inhibition in the Treatment of Advanced BCC </div><div><br/></div>